Falsely low serum prolactin in two cases of invasive macroprolactinoma

Pituitary

Volumn 5, Issue 4, 2002, Pages 261-265

  Schöfl, Christof ^a   Schöfl Siegert, Beate ^a   Hinrich Karstens, Johann ^a   Bremer, Michael ^a   Lenarz, Thomas ^a   Fernandez Cuarezma, Jose Sebastian ^a   Samii, Madjid ^a   von zur Mühlen, Alexander ^a   Brabant, Georg ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cranial nerve palsy; High dose hook effect; Macroprolactinoma; Tumor at the base of the skull

Indexed keywords

CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; HYDROCORTISONE; LEVOTHYROXINE; PROLACTIN; TESTOSTERONE; TESTOSTERONE ENANTATE;

ACUTE DISEASE; ADULT; ARTICLE; BIOASSAY; BLOOD SAMPLING; BONE DESTRUCTION; CANCER INVASION; CARCINOMA; CASE REPORT; CERVICAL SPINE; CHEMOLUMINESCENCE; CRANIAL NERVE PARALYSIS; DIAGNOSTIC TEST; DILUTION; ENDOCRINE FUNCTION TEST; HEARING IMPAIRMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPROLACTINEMIA; HYPOPHYSIS FUNCTION; HYPOPITUITARISM; IRRADIATION; MALE; MEDICAL DECISION MAKING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL BONE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; SKULL BASE TUMOR; SPINE FUSION; SURGICAL TECHNIQUE; TREATMENT PLANNING; TUMOR BIOPSY; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR VOLUME; VISUAL IMPAIRMENT;

ADULT; DOPAMINE AGONISTS; ERGOLINES; FALSE NEGATIVE REACTIONS; HEADACHE; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PITUITARY FUNCTION TESTS; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; SKULL BASE NEOPLASMS; VISION DISORDERS;

EID: 17144475280     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025334001748     Document Type: Article

References (12)

1. Jefferson G. The invasive adenomas of the anterior pituitary (The Sherington Lectures). Liverpool: Liverpool University Press, 1955;3.
2. Pernicone PJ, Scheithauer BW, Sebo TJ et al. Pituitary carcinoma. Cancer 1997;79:804-812.
3. Cunnah D, Besser M. Management of prolactinomas. Clin Endocrinol 1991;34:231-235.
4. Wilson C. Extensive personal experience. Surgical management of pituitary tumors. J Clin Endocrinol Metab 1997;82:2381-2386.
5. Bevan JS, Webster J, Burke CW. Dopamine agonists and pituitary tumor shrinkage. Endocr Rev 1992;13:221-235.
6. Luizzi A, Dallabonzana D, Oppizzi G et al. Low dose of dopamine agonists in the long-term treatment of macroprolactinomas. N Eng J Med 1985;313:656-659.
7. Verhelst J, Abs R, Maiter D et al. Cabergoline in the treatment of hyperprolactinemia: A study in 455 patients. J Clin Endocinol Metab 1999;84:2518-2522.
8. Ahmed M. Pituitary apoplexy revisited. Arch Intern Med 1993;153:2165-2168.
9. Arafah BM, Prunty D, Ybarra J et al. The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J Clin Endocrinol Metab 2000;85:1789-1793.
10. Hobbs GA, Watson M, Hess P. A "hook effect" detected in a two-step immunoassay. J Clin Ligand Assay 1995;18:200-204.
11. Jean E, Blainf, Comtois R. High prolactin levels maybe missed by immunoradiometric assay in patients with macroprolactinomas. Clin Endocrinol 1996;44:305-309.
12. Barkan AL, Chandler WF. Giant pituitary prolactinoma with falsely low serum prolactin: The pitfall of the "high-dose hook effect": Case report. Neurosurgery 1998;42:913-915.